01Need
Clinical burden
Start with the patient and clinical context that makes the unmet need visible.
- Context
- Clinical need and population context
- Confidence
- supported
Women's health
M&A DiligenceStack
Prototype investment-research environment — verified deal provenance, clinical trial search, genomics governance, and cited analytics from public sources.
59 verified deals — SEC EDGAR ingest · HIPAA/GDPR genomics layer · descriptive analytics only. Not PitchBook, not live market feeds, and not investment advice.
Evidence field
Where clinical need is clear, investable visibility is often not.
Lacuna brings biological, clinical, and market context into a single evidence-led view while preserving what remains unknown.
- 02Evidence
Validation context
Trace the evidence that supports the question while retaining its limits and maturity.
- Context
- Available clinical and scientific record
- Limitation
- Evidence maturity, coverage, and source quality may constrain interpretation.
- Confidence
- emerging
Explicit uncertainty
What remains unknown, weakly observed, or insufficiently translated?
- 03Translation
Actionable question
Carry what is known into a decision frame without smoothing over what remains unresolved.
- Context
- Decision pathway and remaining diligence
- Confidence
- emerging
Dataset 2026-09-20 · v9Build …SEC ingest — configure Postgres to enable
Where do you want to start?
99
Companies in our network
51
Verified deals
$21.0B
WH disclosed value (completed)
313
Public sources cited
InsightAmong disclosed valuations, Precision Medicine averages 72× higher than Pelvic Health — the widest sector gap in the dataset (n=6 vs n=2 disclosed).
Cited (survey 2022)
HLTH/Outcomes4Me 2022 (breast cancer, n=1,828): max gap 80/100 (presented with clinical trial as treatment option). Weighted burden 52/100 · median 48/100 · 2 critical. Top priority: patients with full access to medical records ( score 51). Weakest prerequisite: evidence-based standards presented.
Cited 2022 survey — not live Lacuna patient data →
InsightFertility has seen 8 verified acquisitions in the past four years — the highest velocity among all dataset sectors.
P
Payer IntelFeatured
Prior-auth friction, avoidable admin waste, and VC investment signals for payer-aligned women's health deals — built for payer corporate venture context.
Payer VC lens
Choose a workspace
Dashboards are grouped by diligence workflow. Each workspace loads only the panels you need — shareable URLs, less scroll fatigue.
Consumer health
Wearables, wellness apps, and consumer digital health M&A — separate from medicine & biotech.
wearableswellnessdigital health
Separate consumer health trackDeals
Network graph, deal flow, valuation matrix, and acquirer landscape.
networkvaluationacquirers
51 medicine & biotech dealsPayer Ops
Prior-auth friction, claims ops waste, and VC investment signals for payer-aligned women's health deals.
prior authclaims opspayer VC
Research
Clinical trials, evidence maturity, genomics, health equity, and patient empowerment baselines.
clinical trialsevidenceempowerment
Methods
Record quality, observed sector composition, and announcement timing.
qualitycoveragetiming
Intelligence
Reimbursement context, historical acquirer-profile overlap, and dataset export.
reimbursementoverlapexport